Fluid overload in acute heart failure - Re-distribution and other mechanisms beyond fluid accumulation

European Journal of Heart Failure

Volumn 10, Issue 2, 2008, Pages 165-169

  Cotter, Gad ^a   Metra, Marco ^b   Milo Cotter, Olga ^a   Dittrich, Howard C ^c   Gheorghiade, Mihai ^d  

^a Momentum Research Inc   (United States)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Fluid overload; Heart failure

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ARGIPRESSIN; DIURETIC AGENT; RENIN;

ACUTE HEART FAILURE; ARTERY COMPLIANCE; DISEASE CLASSIFICATION; DIURETIC THERAPY; FLUID BALANCE; FLUID INTAKE; HEART PRELOAD; HORMONAL REGULATION; HUMAN; INFLAMMATION; KIDNEY FAILURE; NEUROENDOCRINOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SALT INTAKE; SODIUM BALANCE; VASOPRESSIN RELEASE;

ARGININE VASOPRESSIN; ARTERIES; DISEASE PROGRESSION; EDEMA, CARDIAC; ELASTICITY; HEART FAILURE; HUMANS; KIDNEY FAILURE, CHRONIC; LUNG; PULMONARY EDEMA; RENIN-ANGIOTENSIN SYSTEM; VASCULAR RESISTANCE; VASODILATOR AGENTS; WATER-ELECTROLYTE IMBALANCE;

EID: 38949162580     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2008.01.007     Document Type: Review

References (35)

1. Thom T., Haase N., Rosamond W., et al. Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113 6 (2006) e85-e151
2. Gheorghiade M., Abraham W.T., Albert N.M., et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 296 18 (2006) 2217-2226
3. Yancy C.W., Lopatin M., Stevenson L.W., De Marco T., and Fonarow G.C. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 47 1 (2006) 76-84
4. ADHERE Registry [database] First quarter 2003 benchmark report. Sunnyvale, CA: Scios, Inc Jan 2003.
5. Nieminen M.S., Brutsaert D., Dickstein K., et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 27 22 (2006) 2725-2736
6. Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail 12 1 (2006) 10-38
7. Nieminen M.S., Bohm M., Cowie M.R., et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26 4 (2005) 384-416
8. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112 12 (2005) e154-e235
9. Cleland J.G., Swedberg K., Follath F., et al. The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24 5 (2003) 442-463
10. Mann D.L. Mechanisms and models in heart failure: A combinatorial approach. Circulation 100 9 (1999) 999-1008
11. Cotter G., Moshkovitz Y., Milovanov O., et al. Acute Congestive Heart Failure: A Novel Approach to Its Pathogenesis and Treatment. Eur J Heart Fail 4 (2002) 227-234
12. Verwey H.F., M.S., Sweeney R., et al. Patients symptoms and device based activity for decompensated versus nondecompensated heart failure patients. J Card Fail 12 (2005) 170
13. Lewin J., Ledwidge M., O'Loughlin C., McNally C., and McDonald K. Clinical deterioration in established heart failure: what is the value of BNP and weight gain in aiding diagnosis?. Eur J Heart Fail 7 6 (2005) 953-957
14. Milo-Cotter O., Adams K.F., O'Connor C.M., et al. Acute heart failure associated with high admission blood pressure - a distinct vascular disorder?. Eur J Heart Fail 9 (2007) 178-183
15. Kaluski E., Kobrin I., Zimlichman R., et al. RITZ-5: randomized intravenous TeZosentan (an endothelin-A/B antagonist) for the treatment of pulmonary edema: a prospective, multicenter, double-blind, placebo-controlled study. J Am Coll Cardiol 41 2 (Jan 15 2003) 204-210
16. Balmain S., Padmanabhan N., Ferrel W.R., et al. Differences in arterial compliance, microvascular function and venous capacitance between patients with heart failure and either preserved or reduced left ventricular systolic function. Eur J Heart Fail 9 (2007) 865-871 Epub 2007 Jul 19
17. Kawaguchi M., Hay I., Fetics B., and Kass D.A. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 107 (2003) 714-720
18. Cotter G., Metzkor E., Kaluski E., et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 351 9100 (1998) 389-393
19. Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF). Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial JAMA. 2002 Mar 27;287(12):1531-40. Erratum in: JAMA 2002 Aug 7;288(5):577.
20. Metra M., Dei Cas L., and Bristow M.R. The pathophysiology of acute heart failure - it is a lot about fluid accumulation. Am Heart J 155 (2008) 1-5
21. Schrier R.W. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1). N Engl J Med 319 16 (1988) 1065-1072
22. Schrier R.W. Body fluid volume regulation in health and disease: a unifying hypothesis. Ann Intern Med 113 2 (1990) 155-159
23. Cody R.J., Atlas S.A., Laragh J.H., et al. Atrial natriuretic factor in normal subjects and heart failure patients: Plasma levels and renal, hormonal, and hemodynamic responces to peptide infusion. J Clin Invest 78 (1986) 1362-1374
24. Abraham W.T., Lowes B.D., Ferguson D.A., et al. Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. J Card Fail 4 (1998) 37-44
25. Szatalowicz V.L., Arnold P.E., Chaimovitz C., et al. Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. N Engl J Med 305 5 (Jul 30 1981) 263-266
26. Schrier R.W. Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor?. J Am Coll Cardiol 47 (2006) 1-8
27. Chen H.H., and Schrier R.W. Pathophysiology of volume overload in acute heart failure syndromes. Am J Med 119 12A (2006) S11-S16
28. Milo O., Cotter G., Kaluski E., et al. Inflammatory and neurohormonal activation in cardiogenic pulmonary edema: Implications on the pathogenesis and outcome of acute ischemic versus non-ischemic acute heart failure. Am J Cardiol 92 (2003) 222-226
29. Colombo P.C., Banchs J.E., Celaj S., et al. Endothelial cell activation in patients with decompensated heart failure. Circulation 111 1 (Jan 4 2005) 58-62 Epub 2004 Dec 20
30. Gökhan M.M., and Jacob I.S. Mechanisms of pulmonary edema clearance. Am J Physiol Lung Cell Mol Physiol 289 (2005) L685-L695
31. Maxwell P.A., Ong H.Y., and Nicholls P.D. Influence of progressive renal dysfunction in chronic heart failure. Eur J Heart Fail 4 (2002) 125-130
32. Firth J.D., Raine A.E., and Ledingham J.G. Raised venous pressure: a direct cause of renal sodium retention in oedema?. Lancet 1 8593 (May 7 1988) 1033-1035
33. Vallon V., Miracle C., and Thomson S. Adenosine and kidney function: potential implications in patients with heart failure. Eur J Heart Fail 10 (2008) 177-188 (this issue)
34. Coletta A.P., Tin L., Loh P.H., et al. Clinical trials update from the European Society of Cardiology heart failure meeting: TNT subgroup analysis, darbepoetin alfa, FERRIC-HF and KW-3902. Eur J Heart Fail 8 5 (Aug 2006) 547-549 Epub 2006 Aug 1
35. Whelton A., Lefkowith J.L., West C.R., et al. Cardiorenal effects of celecoxib as compared with the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen. Kidney Int 70 (2006) 1495-1502